China Medical System Holdings Limited (HKG:0867)
12.96
-0.06 (-0.46%)
Mar 17, 2026, 4:08 PM HKT
HKG:0867 Revenue
In the year 2025, China Medical System Holdings had annual revenue of 8.21B CNY with 9.95% growth. China Medical System Holdings had revenue of 4.00B in the half year ending June 30, 2025, a decrease of -13.19%.
Revenue
8.21B CNY
Revenue Growth
+9.95%
P/S Ratio
3.44
Revenue / Employee
1.35M CNY
Employees
6,095
Market Cap
31.46B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.21B | 743.07M | 9.95% |
| Dec 31, 2024 | 7.47B | -544.30M | -6.79% |
| Dec 31, 2023 | 8.01B | -1.14B | -12.43% |
| Dec 31, 2022 | 9.15B | 813.13M | 9.75% |
| Dec 31, 2021 | 8.34B | 1.39B | 20.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| China Resources Pharmaceutical Group | 285.94B |
| The United Laboratories International Holdings | 15.45B |
| Grand Pharmaceutical Group | 11.70B |
| Simcere Pharmaceutical Group | 7.79B |
| Sunshine Lake Pharma | 3.96B |
| Consun Pharmaceutical Group | 3.58B |
| Sihuan Pharmaceutical Holdings Group | 2.30B |
| CanSino Biologics | 1.19B |
China Medical System Holdings News
- 3 months ago - CMS (867.HK/8A8.SG): Innovative Drug Oral JAK1 Inhibitor Povorcitinib Has Been Included in the List of Breakthrough Therapeutic Drugs in China - GlobeNewsWire
- 5 months ago - CMS (867.HK; 8A8.SG) Signed A Distribution Agreement for Ophthalmic Drugs Lucentis® and Beovu® - GlobeNewsWire